Markets:

Overview

News

Currencies

International

Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

121.13 +6.65 (+5.81%)

Streaming Delayed Price Updated: 3:21 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Glaukos Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Dow Jumps 450 Points; UiPath Shares Slide ↗

September 07, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones adding around 450 points on Wednesday.

Via Benzinga

Dow Up 249 Points, Nasdaq Set To Snap Skid ↗

September 07, 2022

Stocks are charging higher this afternoon, though investors are still awaiting the release of the Federal Reserve's Beige Book.

Via Talk Markets

Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session ↗

September 07, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.

Via Benzinga

Glaukos Shares Pop After Positive Data From Ocular Pressure Candidate ↗

September 07, 2022

Via Benzinga

Glaukos Inks Licensing Pact For Rare Eye Disorder Treatment ↗

August 24, 2022

Via Benzinga

Glaukos Receives FDA 510(k) Clearance For iStent infinite ↗

August 03, 2022

The U.S.

Via Benzinga

Coupa Software, Glaukos And Some Other Big Stocks Moving Higher On Wednesday ↗

September 07, 2022

Via Benzinga

What's Going On With Glaukos Shares? ↗

September 07, 2022

Glaukos Corp (NYSE: GKOS) shares are trading higher by 1.87% to $49.00 Wednesday morning after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved...

Via Benzinga

Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR, Achieving Primary Efficacy Endpoints and Demonstrating Favorable Tolerability and Safety Profiles

September 07, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Announces More Than 1 Million iStent® Technologies Implanted Worldwide

September 06, 2022

From Glaukos Corporation

Via Business Wire

Glaukos: Q4 Earnings Insights ↗

February 22, 2022

Glaukos (NYSE:GKOS) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Glaukos...

Via Benzinga

Earnings Scheduled For February 22, 2022 ↗

February 22, 2022

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu...

Via Benzinga

Glaukos Announces Participation in the Wells Fargo Healthcare Conference

August 24, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Stock Scores Rising Price Performance With Jump To 91 RS Rating ↗

August 16, 2022

On Tuesday, Glaukos stock hit an key technical milestone, with its Relative Strength Rating climbing to 91, up from 87 the day before.

Via Investor's Business Daily

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 03, 2022

Via Benzinga

Glaukos: Q2 Earnings Insights ↗

August 03, 2022

Glaukos (NYSE:GKOS) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Glaukos missed estimated earnings by...

Via Benzinga

Glaukos Announces FDA 510(k) Clearance of iStent infinite®

August 03, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Corporation Announces Second Quarter 2022 Financial Results

August 03, 2022

From Glaukos Corporation

Via Business Wire

Glaukos to Release Second Quarter 2022 Financial Results after Market Close on August 3

July 13, 2022

From Glaukos Corporation

Via Business Wire

The 6 Most Aggressive Growth Stocks to Buy in July ↗

July 12, 2022

These are the 6 most aggressive growth stocks to buy in July. They reflect huge potential growth in their sales and/or their earnings.

Via InvestorPlace

Glaukos Announces Participation in the William Blair Growth Stock Conference

June 02, 2022

From Glaukos Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022 ↗

July 12, 2022

Upgrades

Via Benzinga

Glaukos Announces Participation in the Piper Sandler Virtual Ophthalmology Symposium

May 20, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Corporation Announces First Quarter 2022 Financial Results

May 04, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting

April 21, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Announces the Release of its 2021 Sustainability Report

April 20, 2022

From Glaukos Corporation

Via Business Wire

Glaukos to Release First Quarter 2022 Financial Results after Market Close on May 4

April 13, 2022

From Glaukos Corporation

Via Business Wire

Sight Sciences' Q4 Earnings, FY22 Guidance Beat Street View ↗

March 25, 2022

Sight Sciences Inc (NASDAQ: SGHT) has treated the first patient in the TRIDENT trial evaluating OMNI Surgical System compared to Glaukos Corp's (NYSE...

Via Benzinga

Glaukos Announces Commencement of Phase 2 Corneal Health Clinical Program for Third-Generation iLink™ Therapy

March 14, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Corporation Announces Fourth Quarter and Full Year 2021 Financial Results

February 22, 2022

From Glaukos Corporation

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.